Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Change in Account Payables (2020 - 2025)

GoHealth's Change in Account Payables history spans 6 years, with the latest figure at -$8.0 million for Q3 2025.

  • For Q3 2025, Change in Account Payables fell 273.96% year-over-year to -$8.0 million; the TTM value through Sep 2025 reached -$3.5 million, down 143.9%, while the annual FY2024 figure was -$5.1 million, 297.97% down from the prior year.
  • Change in Account Payables for Q3 2025 was -$8.0 million at GoHealth, down from -$409000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $12.3 million in Q4 2023 and bottomed at -$14.1 million in Q1 2022.
  • The 5-year median for Change in Account Payables is -$409000.0 (2025), against an average of $23105.3.
  • The largest annual shift saw Change in Account Payables surged 462.58% in 2021 before it crashed 996.37% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $12.2 million in 2021, then tumbled by 52.56% to $5.8 million in 2022, then surged by 113.08% to $12.3 million in 2023, then crashed by 106.43% to -$792000.0 in 2024, then crashed by 914.52% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Change in Account Payables are -$8.0 million (Q3 2025), -$409000.0 (Q2 2025), and $5.7 million (Q1 2025).